2019年成都中医药推免生。

2022年6月，四川大学攻读博士学位

Dehua Lu, Lailiang Qu, Cheng Wang, Heng Luo, Shang Li, Fucheng Yin, Xingchen Liu, Xinye Chen, Zhongwen Luo, Ningjie Cui, Wan Peng, Limei Ji, Lingyi Kong*, and  Xiaobing Wang*. Harmine-Based Dual Inhibitors Targeting Histone Deacetylase (HDAC) and DNA as a Promising Strategy for Cancer Therapy. Bioorganic Chemistry (IF: 5.275), 2022, 120, 105604. DOI: 10.1016/j.bioorg.2022.105604

LIU Xingchen, WANG Xiaobing.  

Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents  

Chin J Nat Med, 2022, 20(11): 814-829. 

doi: 10.1016/S1875-5364(22)60238-3.